Gaudium IVF and Women Health Ltd
Gaudium IVF | 544709
Stock Charts
No Information Available
Stock charts information is not available at this time.
Stock Performance
Ratios
About Company
- Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana
- Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center
- Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years
- Gaudium IVF is founded by the Promoter Dr
- Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited
- The Company offer a complete array of specialized fertility and reproductive health services
- Their treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI) and ovulation induction, all treatment is carefully designed to address a variety of infertility challenges for both male and female
- Its facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques
- For fertility preservation, Company offer cryopreservation services for eggs freezing for future fertilization, utilizing advanced technology to ensure optimal success rates in future IVF cycles
- It further provide laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Gaudium IVF and Women Health Ltd?
The current share price of Gaudium IVF and Women Health Ltd (Gaudium IVF) is ₹104.12. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Gaudium IVF and Women Health Ltd?
The Price-to-Earnings (P/E) ratio of Gaudium IVF and Women Health Ltd is 104.12. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd has a 52-week high of ₹104.00 and a 52-week low of ₹69.18. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Gaudium IVF and Women Health Ltd?
The Earnings Per Share (EPS) of Gaudium IVF and Women Health Ltd is ₹3.12. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd has a Return on Equity (ROE) of 51.57%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
